TrialCancer medicine2024

Inosine enhances the efficacy of immune-checkpoint inhibitors in advanced solid tumors: A randomized, controlled, Phase 2 study.

Haiqing Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.